The periodical about the pharmaceutical and medical equipment markets
(Russian pharmacies) - specialized periodical edition for pgarmacy professionals
Medical Council - Scientific Journal for Physicians
Alvogen, today announced that it has acquired five hormonal branded products from Bayer Pharma AG in Russia and CIS.
First commercial shipment initiate the launch by Oasmia's strategic partner Pharmasyntez to distribute the Company's lead cancer product across the Russian Federation as well as the Commonwealth of Independent States.
The two countries have distinctly different approaches to doing business.
R-PHARM US announces the acquisition of IXEMPRA (ixabepilone) from Bristol-Myers Squibb (NYSE:BMY). IXEMPRA received marketing approval from the U.S. Food and Drug Administration in 2007 and in 18 other markets globally.
1 - 5 из 800
Scientists from the Belozersky Research Institute at Moscow State University and the Wenner-Gren Institute at the University of Stockholm have developed a new medicine against obesity. It proved successful on mice, and scientists say that clinical tests on humans will start in two years.
Начало | Пред. |
programmer of electronic software products